ArticleFrontiers in pharmacology2025
Integrative multi-omics and experimental analyses implicate PTK2 as a lorazepam-associated biomarker and potential therapeutic target in ovarian cancer.
Xia Hong et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.